Vitality LifeJun 25 2018

Vitality chooses GBST for investment product

twitter-iconfacebook-iconlinkedin-iconmail-iconprint-icon
Search supported by
Vitality chooses GBST for investment product

Vitality has revealed it worked with GBST to build the technology for the creation of its VitalityInvest product range.

Vitality is launching a range of active and passively managed funds, with the active range managed by Investec and the passives run by Vanguard.

Funds run by other providers will also be available on the platform.

The company worked with GBST to build the technology behind the service.

Vitality are the first business to use GBST’s Catalyst System.

Catalyst provides advisers with the ability to onboard and service their customers, with access to illustrations, applications, transfers, client management, engaging financial planning tools and document storage, all accessed, delivered, actioned and stored via a secure online interface.

End investors can also self-service on their account, with access to their daily valuations, holdings and all documents relating to their investments through their desktop, tablet or phone.

Vitality will be able to integrate data from its existing health and protection systems into the new system.

Investec’s UK managing director David Aird said he wants the company's arrangement with Vitality to be "multi-decade".

David Simpson, head of EMEA at GBST, said: "We are proud to be Vitality’s strategic technology partner on this initiative. It has been a great project to be involved in over the past 12 months, allowing us to really push innovation and think differently in terms of approach.

"Vitality is also the first UK user of our new digital proposition, Catalyst, and we are excited to showcase the combination of digital design capability utilising the latest innovations in technology and proven integration services.

"We look forward to working with Vitality as it continues to develop its investment proposition with new features and functionality repeating the successes of its life and health business."

david.thorpe@ft.com